Aqua Bio Technology — Director's Dealing 2024

Jan 30, 2024

AQUA BIO TECHNOLOGY ASA - MANDATORY NOTIFICATION OF TRADES AND DISCLOSURE OF LARGE SHAREHOLDING

AQUA BIO TECHNOLOGY ASA - MANDATORY NOTIFICATION OF TRADES AND DISCLOSURE OF LARGE SHAREHOLDING

30.1.2024 17:17:34 CET | Aqua Bio Technology ASA | Additional regulated

information required to be disclosed under the laws of a member state

Reference is made to the stock exchange notices from Aqua Bio Technology ASA

(the "Company") on 30 January 2024 regarding the completion of a private

placement raising gross proceeds of approximately NOK 12.46 million.

The following close associates of primary insiders and primary insiders of the

Company have been allocated shares in the private placement:

* RH Industri AS, a close associate of board member Roger Hofseth, has been

allocated 300,000 shares;

* Swelandia International AB, a close associate of board member Jan Petterson,

has been allocated 50,000 shares; and

* Per Egil Borge, chairman of wholly owned subsidiary of the Company Skinteam

Norge AS, has been allocated 78,000 shares.

Please see the attached forms in accordance with article 19 of the Market Abuse

Regulation.

Viddas AS has been allocated a total of 1,000,000 shares in the private

placement. Following completion of the private placement, Viddas AS and close

associates will own a total of 3,073,945 shares in the Company, representing

5.32% of the outstanding shares and voting rights in the Company, and has

thereby exceeded the 5% threshold pursuant to section 4-2 of the Norwegian

Securities Trading Act.

This information is subject to the disclosure requirements in article 19 of the

Regulation EU 596/2014 and sections 4-2 and 5-12 of the Norwegian Securities

Trading Act.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/2878/4011/Download%20announcement

%20as%20PDF.pdf

PDMR notification form RH Industri AS.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/2878/4008/PDMR%20notification%20f

orm%20RH%20Industri%20AS.pdf

PDMR notification form Swelandia International AB.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/2878/4009/PDMR%20notification%20f

orm%20Swelandia%20International%20AB.pdf

PDMR notification form Per Egil Borge.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/2878/4010/PDMR%20notification%20f

orm%20Per%20Egil%20Borge.pdf